References
1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415(6868):219-26.
2. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circulation: Arrhythmia and Electrophysiology. 2008;1(1):62-73.
3. Lip GY, Tse H-F. Management of atrial fibrillation. The Lancet. 2007;370(9587):604-18.
4. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150-61.
5. Association DwtscotEHR, Surgery EbtEAfC-T, Members ATF, Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European heart journal. 2010;31(19):2369-429.
6. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation. New England Journal of Medicine. 2002;347(23):1825-33.
7. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. New England Journal of Medicine. 2020;383(14):1305-16.
8. Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. New England Journal of Medicine. 2020;384(4):305-15.
9. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. New England Journal of Medicine. 2018;378(5):417-27.
10. Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kennebäck G, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. Jama. 2019;321(11):1059-68.
11. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. Journal of the American College of Cardiology. 2004;43(11):2044-53.
12. Spencer K, Mor-Avi V, Gorcsan Jr, DeMaria A, Kimball T, Monaghan M, et al. Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study. Heart. 2001;85(3):272-7.
13. Heppell R, Berkin K, McLenachan J, Davies J. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 1997;77(5):407-11.
14. Al-Saady N, Obel O, Camm A. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999;82(5):547-54.
15. Barbero U, Ho SY. Anatomy of the atria. Herzschrittmachertherapie + Elektrophysiologie. 2017;28(4):347-54.
16. Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. Journal of cardiovascular electrophysiology. 2010;21(9):973-82.
17. Chava R, Turagam MK, Lakkireddy DD. Left Atrial Appendage Occlusion: What Are the Options and Where is the Evidence? J Innov Card Rhythm Manag. 2018;9(4):3095-106.
18. Marrouche NF, Greene T, Dean JM, Kholmovski EG, Boer LMd, Mansour M, et al. Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design. Journal of cardiovascular electrophysiology. 2021;32(4):916-24.
19. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study. JAMA. 2014;311(5):498-506.
20. Masci A, Barone L, Dedè L, Fedele M, Tomasi C, Quarteroni A, et al. The Impact of Left Atrium Appendage Morphology on Stroke Risk Assessment in Atrial Fibrillation: A Computational Fluid Dynamics Study. Frontiers in Physiology. 2019;9(1938).
21. Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ, et al. Usefulness of Left Atrial Volume in Predicting First Congestive Heart Failure in Patients ≥65 Years of Age With Well-Preserved Left Ventricular Systolic Function. The American Journal of Cardiology. 2005;96(6):832-6.
22. Dernellis JM, Stefanadis CI, Zacharoulis AA, Toutouzas PK. Left atrial mechanical adaptation to long-standing hemodynamic loads based on pressure–volume relations. The American journal of cardiology. 1998;81(9):1138-43.
23. Bakalli A, Kamberi L, Pllana E, Zahiti B, Dragusha G, Brovina A. The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy. Turk Kardiyol Dern Ars. 2010;38(2):90-4.
24. Xu Y, Zhao L, Zhang L, Han Y, Wang P, Yu S. Left Atrial Enlargement and the Risk of Stroke: A Meta-Analysis of Prospective Cohort Studies. Front Neurol. 2020;11:26-.
25. Taina M, Vanninen R, Hedman M, Jäkälä P, Kärkkäinen S, Tapiola T, et al. Left Atrial Appendage Volume Increased in More Than Half of Patients with Cryptogenic Stroke. PLOS ONE. 2013;8(11):e79519.
26. Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. Journal of the American College of Cardiology. 2012;60(6):531-8.
27. Korhonen M, Muuronen A, Arponen O, Mustonen P, Hedman M, Jäkälä P, et al. Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation. PLoS One. 2015;10(3):e0118822.
28. Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, et al. Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores. Heart Rhythm. 2013;10(6):921-5.
29. Lupercio F, Ruiz JC, Briceno DF, Romero J, Villablanca PA, Berardi C, et al. Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: a meta-analysis. Heart Rhythm. 2016;13(7):1402-9.
30. Khurram IM, Dewire J, Mager M, Maqbool F, Zimmerman SL, Zipunnikov V, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart rhythm. 2013;10(12):1843-9.
31. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease: additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. Journal of the American College of Cardiology. 1993;22(7):1972-82.
32. Yamada A, Hashimoto N, Fujito H, Hatta T, Saito Y, Otsuka N, et al. Comprehensive assessment of left atrial and ventricular remodeling in paroxysmal atrial fibrillation by the cardiovascular magnetic resonance myocardial extracellular volume fraction and feature tracking strain. Scientific reports. 2021;11(1):1-12.
33. Donal E, Yamada H, Leclercq C, Herpin D. The left atrial appendage, a small, blind-ended structure: a review of its echocardiographic evaluation and its clinical role. Chest. 2005;128(3):1853-62.
34. Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC: Cardiovascular imaging. 2014;7(12):1251-65.
35. Cha Y-M, Redfield MM, Shen W-K, Gersh BJ. Atrial Fibrillation and Ventricular Dysfunction. Circulation. 2004;109(23):2839-43.
36. Lee JM, Shim J, Uhm J-S, Kim YJ, Lee H-J, Pak H-N, et al. Impact of Increased Orifice Size and Decreased Flow Velocity of Left Atrial Appendage on Stroke in Nonvalvular Atrial Fibrillation. American Journal of Cardiology. 2014;113(6):963-9.
37. Syed FF, DeSimone CV, Friedman PA, Asirvatham SJ. Left atrial appendage exclusion for atrial fibrillation. Cardiol Clin. 2014;32(4):601-25.